GlassScriptPhysician profile
Nancy M Willis-Smith
NPI 1144206673
$470.51
in general payments reported to CMS, 2019-2025
16 companies · $39.70 in 2025
The $39.70 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $50.86 · 2022: $134 · 2023: $215 · 2024: $30.85 · 2025: $39.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $285.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $60.92 | 2021-2023 | Abilify Maintena, Rexulti |
| Abbvie INC. | $57.46 | 2021-2023 | |
| Acella Pharmaceuticals, LLC | $56.35 | 2023 | NP Thyroid 60 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.40 | 2022-2023 | Jardiance |
| Novo Nordisk INC | $31.62 | 2023-2024 | Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.22 | 2022-2024 | Xifaxan |
| Lilly USA, LLC | $27.82 | 2022-2023 | Mounjaro |
| Kowa Pharmaceuticals America, INC. | $27.39 | 2021-2023 | Livalo |
| Vanda Pharmaceuticals INC. | $25.44 | 2022 | |
| Axsome Therapeutics, INC. | $23.76 | 2025 | Auvelity |
| Exact Sciences Corporation | $18.52 | 2023 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $18.10 | 2023 | Farxiga |
| Novartis Pharmaceuticals Corporation | $17.26 | 2022 | |
| Globus Medical, INC. | $15.94 | 2025 | Senza |
| Merck Sharp & Dohme LLC | $15.33 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $9.98 | 2023 | Adlarity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Willis-Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.